D.V. Erbe

693 total citations
10 papers, 594 citations indexed

About

D.V. Erbe is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, D.V. Erbe has authored 10 papers receiving a total of 594 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Radiology, Nuclear Medicine and Imaging and 5 papers in Immunology. Recurrent topics in D.V. Erbe's work include Monoclonal and Polyclonal Antibodies Research (6 papers), Glycosylation and Glycoproteins Research (3 papers) and Galectins and Cancer Biology (3 papers). D.V. Erbe is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (6 papers), Glycosylation and Glycoproteins Research (3 papers) and Galectins and Cancer Biology (3 papers). D.V. Erbe collaborates with scholars based in United States and Canada. D.V. Erbe's co-authors include Michael W. Fanger, Ichiro Kurane, R F Graziano, Jane Collins, Brian K. Brandley, B A Wolitzky, Francis A. Ennis, Li Shen, Leonard G. Presta and Laurence A. Lasky and has published in prestigious journals such as The Journal of Cell Biology, The Journal of Immunology and Journal of General Virology.

In The Last Decade

D.V. Erbe

10 papers receiving 557 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D.V. Erbe United States 10 260 225 193 126 99 10 594
Margot Larkin United Kingdom 9 508 2.0× 209 0.9× 125 0.6× 114 0.9× 46 0.5× 10 730
Laura Bolling United States 7 211 0.8× 83 0.4× 73 0.4× 21 0.2× 197 2.0× 7 646
Peter Rohwer Germany 16 149 0.6× 409 1.8× 44 0.2× 79 0.6× 24 0.2× 22 656
W L Cosand United States 17 441 1.7× 325 1.4× 96 0.5× 238 1.9× 22 0.2× 19 960
Gavin Nicoll United Kingdom 9 572 2.2× 582 2.6× 45 0.2× 79 0.6× 29 0.3× 10 950
Irina Mirkina Austria 16 191 0.7× 308 1.4× 74 0.4× 34 0.3× 45 0.5× 26 590
L E Guagliardi United States 4 288 1.1× 465 2.1× 35 0.2× 123 1.0× 38 0.4× 7 766
Michael L. Key United States 7 263 1.0× 331 1.5× 45 0.2× 54 0.4× 40 0.4× 8 646
Stephen Horváth United States 13 178 0.7× 462 2.1× 36 0.2× 101 0.8× 47 0.5× 29 732
Claudine Guérin-Marchand France 15 321 1.2× 427 1.9× 87 0.5× 63 0.5× 43 0.4× 21 902

Countries citing papers authored by D.V. Erbe

Since Specialization
Citations

This map shows the geographic impact of D.V. Erbe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D.V. Erbe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D.V. Erbe more than expected).

Fields of papers citing papers by D.V. Erbe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D.V. Erbe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D.V. Erbe. The network helps show where D.V. Erbe may publish in the future.

Co-authorship network of co-authors of D.V. Erbe

This figure shows the co-authorship network connecting the top 25 collaborators of D.V. Erbe. A scholar is included among the top collaborators of D.V. Erbe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D.V. Erbe. D.V. Erbe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Erbe, D.V., Lori D. Klaman, Douglas Wilson, et al.. (2009). Prodrug delivery of novel PTP1B inhibitors to enhance insulin signalling. Diabetes Obesity and Metabolism. 11(6). 579–588. 17 indexed citations
2.
Perreault, Mylène, Sarah Will, Kimberly Harding, et al.. (2009). Modulation of nutrient sensing nuclear hormone receptors promotes weight loss through appetite suppression in mice. Diabetes Obesity and Metabolism. 12(3). 234–245. 10 indexed citations
3.
Moretto, Alessandro F., Michael J. Smith, Z. Wan, et al.. (2005). Bicyclic and tricyclic thiophenes as protein tyrosine phosphatase 1B inhibitors. Bioorganic & Medicinal Chemistry. 14(7). 2162–2177. 68 indexed citations
4.
Kurane, Ichiro, et al.. (1993). Neuraminidase Augments Fc  Receptor II-Mediated Antibody-Dependent Enhancement of Dengue Virus Infection. Journal of General Virology. 74(5). 839–844. 25 indexed citations
5.
Erbe, D.V., Susan R. Watson, Leonard G. Presta, et al.. (1993). P- and E-selectin use common sites for carbohydrate ligand recognition and cell adhesion.. The Journal of Cell Biology. 120(5). 1227–1235. 125 indexed citations
7.
8.
Erbe, D.V., E. R. Pfefferkorn, & M W Fanger. (1991). Functions of the various IgG Fc receptors in mediating killing of Toxoplasma gondii. The Journal of Immunology. 146(9). 3145–3151. 18 indexed citations
9.
Erbe, D.V., Jane Collins, Li Shen, R F Graziano, & Michael W. Fanger. (1990). The effect of cytokines on the expression and function of Fc receptors for IgG on human myeloid cells. Molecular Immunology. 27(1). 57–67. 90 indexed citations
10.
Graziano, R F, D.V. Erbe, & M W Fanger. (1989). The mechanisms of antibody-dependent killing mediated by lymphoid and myeloid cells are distinct based on different divalent cation requirements.. The Journal of Immunology. 143(12). 3894–3900. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026